-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
While the whole country is actively fighting against the new crown epidemic, the delay in resumption of work and the obstruction of logistics caused by the epidemic prevention and control all have a certain impact on the production and operation of chemical enterprises
At the meeting, Zhao Haisheng, EHS Director of Olin Group Asia Pacific, shared the future positioning of EHS in the post-epidemic era
Zhao Junbo, EHS director of Jiangxi Jimin Trust Group, made a report on the topic of "pharmaceutical industry management system upgrade, scientific emergency to break the epidemic situation".
Hou Ping, HSE&S manager of AkzoNobel's North Asia region, titled "The Implementation of Corporate Business Sustainability Plans During the Epidemic", focusing on the company's internal operations and external aspects, and the points that the company needs to pay attention to during the epidemic
Gao Yongyi, Director of Health, Safety and Environmental Protection of Nouryon (China) Asia Pacific, shared the theme from the perspective of factory operation management under the situation of epidemic closure
Chen Zanliu, founder of Mahoupao Chemical, discussed the corresponding risk issues around the attributes of the chemical industry itself
In the interactive session after the theme sharing, the audience asked questions about the problems in the chemical industry during the epidemic, especially in terms of safety and operation, and several experts answered them